In the second part of this roundtable discussion, participants highlight best practices for reaching underrepresented populations and increasing their awareness of clinical trials.
Related Posts
Usage of Patient-Reported Outcomes in Blood Cancer Clinical Trials
Image Credit: © putilov_denis – stock.adobe.com In recent years, there has been a growing interest in the use of patient-reported…
The Current State of Diversity in Randomized Clinical Trials for Peripheral Artery Disease
Image Credit: © Jakub Krechowicz – stock.adobe.com A recent study published by the National Library of Medicine reviewed diversity in…
Vepdegestrant Granted FDA Fast Track Designation for ER-Positive/HER2-Negative Breast Cancer
Image credit: LASZLO | stock.adobe.com. The FDA has granted Fast Track designation to Arvinas’ and Pfizer’s vepdegestrant (ARV-471) monotherapy for…